BioCentury | May 6, 2020
Targets & Mechanisms

Los Alamos team opens door to allosteric COVID-19 countermeasures

...England, the Netherlands, New York state and Australia. However, when looking at COVID-19 patients in Sheffield...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...is expected to enter the clinic in 2021. Kymab’s anti-TNFRS11B mAb for PAH University of Sheffield...
BioCentury | May 20, 2019
Finance

Boehringer Ingelheim, UCB venture arms seed hearing loss newco Rinri

...Boehringer's Detlev Mennerich told BioCentury that the fund first came across the technology, developed by Sheffield...
...a rodent model of hearing loss. Rivolta is professor of Sensory Stem Cell Biology at Sheffield...
BioCentury | Dec 4, 2018
Distillery Therapeutics

Inflammation

...Branch at Galveston, Galveston, Texas email: sboldogh@utmb.edu CONTACT: Thomas Helleday, Karolinska Institute, Stockholm, Sweden email: t.helleday@sheffield.ac.uk Sandi...
BioCentury | Nov 30, 2018
Emerging Company Profile

Afyx: Mucosal drug delivery

...II Founded: 2014 by Jens Hansen and Lars Hellerung Christiansen University collaborators: The University of Sheffield...
BioCentury | Nov 16, 2018
Preclinical News

Preventing DNA repair blocks inflammation

...lungs and airways. The Helleday Foundation, founded by author Thomas Helleday of the University of Sheffield...
...Phase I trials within two years to treat airway inflammation diseases. Sandi Wong Karolinska Institute The University of Sheffield 8-oxoguanine...
BioCentury | Apr 13, 2018
Emerging Company Profile

Reversing Neuropathy

...Mount Sinai, Radboud University Medical Center, University of Leuven, University of Pittsburgh, The University of Sheffield...
BioCentury | Feb 24, 2018
Regulation

Herculean task for DMD

...loss of ambulation. HERCULES is developing the DMD-focused metric in collaboration with The University of Sheffield’s...
...Inc. (NASDAQ:SLDB), Cambridge, Mass. Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT), Abingdon, U.K. The University of Sheffield, Sheffield...
BioCentury | Jan 12, 2018
Company News

Duchenne UK launches data-sharing collaboration

...Ltd. (NASDAQ:WVE), which are all developing DMD therapies. Additionally, University of Leicester and University of Sheffield...
...Mass. Business: Musculoskeletal Mary Romeo Pfizer Inc. PTC Therapeutics Inc. Roche Sarepta Therapeutics Inc. Solid Biosciences LLC Summit Therapeutics plc The University of Sheffield University...
BioCentury | Jan 11, 2018
Company News

Duchenne UK launches data-sharing initiative

...Ltd. (NASDAQ:WVE), which are all developing DMD therapies. Additionally, University of Leicester and University of Sheffield...
...3, 2017) . Mary Romeo Pfizer Inc. PTC Therapeutics Inc. Roche Sarepta Therapeutics Inc. Solid Biosciences LLC Summit Therapeutics plc The University of Sheffield University...
Items per page:
1 - 10 of 227
BioCentury | May 6, 2020
Targets & Mechanisms

Los Alamos team opens door to allosteric COVID-19 countermeasures

...England, the Netherlands, New York state and Australia. However, when looking at COVID-19 patients in Sheffield...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...is expected to enter the clinic in 2021. Kymab’s anti-TNFRS11B mAb for PAH University of Sheffield...
BioCentury | May 20, 2019
Finance

Boehringer Ingelheim, UCB venture arms seed hearing loss newco Rinri

...Boehringer's Detlev Mennerich told BioCentury that the fund first came across the technology, developed by Sheffield...
...a rodent model of hearing loss. Rivolta is professor of Sensory Stem Cell Biology at Sheffield...
BioCentury | Dec 4, 2018
Distillery Therapeutics

Inflammation

...Branch at Galveston, Galveston, Texas email: sboldogh@utmb.edu CONTACT: Thomas Helleday, Karolinska Institute, Stockholm, Sweden email: t.helleday@sheffield.ac.uk Sandi...
BioCentury | Nov 30, 2018
Emerging Company Profile

Afyx: Mucosal drug delivery

...II Founded: 2014 by Jens Hansen and Lars Hellerung Christiansen University collaborators: The University of Sheffield...
BioCentury | Nov 16, 2018
Preclinical News

Preventing DNA repair blocks inflammation

...lungs and airways. The Helleday Foundation, founded by author Thomas Helleday of the University of Sheffield...
...Phase I trials within two years to treat airway inflammation diseases. Sandi Wong Karolinska Institute The University of Sheffield 8-oxoguanine...
BioCentury | Apr 13, 2018
Emerging Company Profile

Reversing Neuropathy

...Mount Sinai, Radboud University Medical Center, University of Leuven, University of Pittsburgh, The University of Sheffield...
BioCentury | Feb 24, 2018
Regulation

Herculean task for DMD

...loss of ambulation. HERCULES is developing the DMD-focused metric in collaboration with The University of Sheffield’s...
...Inc. (NASDAQ:SLDB), Cambridge, Mass. Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT), Abingdon, U.K. The University of Sheffield, Sheffield...
BioCentury | Jan 12, 2018
Company News

Duchenne UK launches data-sharing collaboration

...Ltd. (NASDAQ:WVE), which are all developing DMD therapies. Additionally, University of Leicester and University of Sheffield...
...Mass. Business: Musculoskeletal Mary Romeo Pfizer Inc. PTC Therapeutics Inc. Roche Sarepta Therapeutics Inc. Solid Biosciences LLC Summit Therapeutics plc The University of Sheffield University...
BioCentury | Jan 11, 2018
Company News

Duchenne UK launches data-sharing initiative

...Ltd. (NASDAQ:WVE), which are all developing DMD therapies. Additionally, University of Leicester and University of Sheffield...
...3, 2017) . Mary Romeo Pfizer Inc. PTC Therapeutics Inc. Roche Sarepta Therapeutics Inc. Solid Biosciences LLC Summit Therapeutics plc The University of Sheffield University...
Items per page:
1 - 10 of 227